Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
South Korea’s KOSPI Enters Bear Market Despite Remaining 2026’s Best-Performing Major Stock Index 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Gold Prices Fall as US-Iran Conflict, Rising Oil Prices Fuel Fed Rate Concerns 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens 
China Trade Surplus Hits $125.6 Billion as June Exports, Imports Smash Forecasts 
EU Weighs New Trade Restrictions on Israeli West Bank Settlements 
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Oil Prices Jump as U.S.-Iran Conflict and Strait of Hormuz Tensions Shake Global Markets 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Merck, a leading science and technology company that operates across life science, healthcare and electronics, has bought the chemical business of Mecaro Co. Ltd., a Korean company specializing in materials and components for semiconductors.
Merck acquired Mecaro in an effort to boost its line-up of materials used for the production of semiconductor products. The German firm further explained on Wednesday, Aug. 17, that the deal is part of the company’s electronics business unit’s “Level Up” growth program.
The agreement also includes investments of more than €3 billion or around $3.05 billion from 2021 to 2025 for innovation and capacities, where the focus will be four key priorities which are: scale, technology, portfolio, and capabilities.
At any rate, according to The Korea Times, the acquisition deal between Merck and Mecaro is worth €110 million. The pay scheme involves an upfront cash payment of €75 million and contingent milestone payments of up to €35 million.
The deal is expected to be completed and closed within the fourth quarter of this year. But then again, just like any other acquisition transaction, this is still subject to regulatory clearance and other customary closing conditions.
Under the agreement, Merck will be securing the production plant of Mecaro located in Eumseong, North Chungcheong Province, as well as its research and development (R&D) facility in Daejeon. It learned that Mecaro has about 100 dedicated staff and mainly produces precursors that are used in Thin Film deposition.
“In acquiring this portion of Mecaro’s business, we will continue to expand a key segment of our Semiconductor Solutions portfolio,” Merck’s chief executive officer of electronics and board member, Kai Beckmann, said in a press release.
He added, “Simultaneously, we are building on our localization efforts and gaining a state-of-the-art production facility in Eumseong and an R&D lab in Daejeon, both supporting our capacity expansion plans and these turnkey spaces will be one of the crucial elements in executing our Level Up investments in Korea.”
Mecaro’s president and CEO, Jae Jung Lee, further said it is looking forward to the partnership.
